content-image

Achelous Partners advises Valeant Pharmaceuticals (NYSE: VRX) on its acquisition of ophthalmology and orthopedic assets from Croma Pharma GmbH

Valeant Europe today announced in Principle to Distribute Croma Ophthalmology and Orthopaedics products in Western Europe.

Categories : Uncategorized ,